|Podcasts|September 14, 2016

Drug Formulary Exclusions: Dr Patricia Salber Interviews Dr James Chambers

Patricia Salber, MD, MBA, of The Doctor Weighs In, interviewed James D. Chambers, PhD, to discuss his findings on the impact of formulary drug exclusion policies.

In August, The American Journal of Managed Care published a study from Tufts Medical Center researchers, who analyzed findings from 26 studies to determine how drug exclusion policies affect patients and healthcare costs. They found that in most cases, exclusion policies work.

Patricia Salber, MD, MBA, of The Doctor Weighs In, interviewed the lead author, James D. Chambers, PhD, to discuss his findings further.

Read the study.

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Drug Formulary Exclusions: Dr Patricia Salber Interviews Dr James Chambers

Related Content

How Often Do Health Insurers Deny Doctor-Recommended Care?

Acoramidis Shows Durable Benefit at 54 Months in ATTR-CM

Sudden Death in HFpEF Often Preceded by Clinical Decline

Community Advanced Therapy Access Drives Equity: Fran Gregory, PharmD

High Out-of-Pocket Costs Raise Food Insecurity Risk by Up to 90% in Households With Children

Trending on AJMC

FDA Issues Complete Response Letter for Cingulate's Once-Daily ADHD Drug CTx-1301

New Therapies Offer Hope for Vitiligo, an Often Misunderstood and Undertreated Disease

Andes Hantavirus FAQs: What to Know as Quarantined Cruise Passengers Return Home

Cancer’s Hidden Wound: Trauma From Diagnosis Through Survivorship

Odronextamab Plus CHOP in Newly Diagnosed Diffuse Large B-Cell Lymphoma: Matthew Matasar, MD